SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Exelixis, Inc. And Sankyo Company, Ltd. Sign Collaboration Agreement To Develop Novel Therapies For Cardiovascular Disease; $20 Million Upfront Payment